The Sanger sequencing confirmed the KRAS gene mutations in the three cancer patients (Figure 4B): codon 12 mutations (GGT>AGT, GGT>GCT), codon 12 mutations (GGT>AGT, GGT>AGA), and mutation in codon 13 (GGC>GAC). Here, KRAS is linked to cancer.